KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) Non Operating Income: 2010-2025

Historic Non Operating Income for Dynavax Technologies (DVAX) over the last 16 years, with Sep 2025 value amounting to -$27,000.

  • Dynavax Technologies' Non Operating Income rose 82.24% to -$27,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$701,000, marking a year-over-year decrease of 352.26%. This contributed to the annual value of $293,000 for FY2024, which is 292.76% up from last year.
  • According to the latest figures from Q3 2025, Dynavax Technologies' Non Operating Income is -$27,000, which was up 95.47% from -$596,000 recorded in Q2 2025.
  • Dynavax Technologies' 5-year Non Operating Income high stood at $557,000 for Q1 2021, and its period low was -$596,000 during Q2 2025.
  • For the 3-year period, Dynavax Technologies' Non Operating Income averaged around -$90,400, with its median value being -$49,000 (2023).
  • Per our database at Business Quant, Dynavax Technologies' Non Operating Income spiked by 339.13% in 2024 and then crashed by 518.81% in 2025.
  • Over the past 5 years, Dynavax Technologies' Non Operating Income (Quarterly) stood at $300,000 in 2021, then plummeted by 42.00% to $174,000 in 2022, then tumbled by 312.64% to -$370,000 in 2023, then soared by 193.24% to $345,000 in 2024, then surged by 82.24% to -$27,000 in 2025.
  • Its Non Operating Income stands at -$27,000 for Q3 2025, versus -$596,000 for Q2 2025 and -$423,000 for Q1 2025.